Federal Register / Vol. 76, No. 73 / Friday, April 15, 2011 / Notices 21369 

environmental chemicals, physical 

substances, or mixtures (collectively 

referred to as ‘‘substances’’) cause 

adverse effects on reproduction and/or 

development and provide opinion on 

whether these substances are hazardous 

for humans. Information about CERHR 

can be obtained from its homepage 

(http://cerhr.niehs.nih.gov). 

Dated: April 7, 2011. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2011–9182 Filed 4–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Meeting of the Presidential 

Commission for the Study of 

Bioethical Issues 

AGENCY: Presidential Commission for 

the Study of Bioethical Issues, Office of 

the Assistant Secretary for Health, 

Department of Health and Human 

Services. 

ACTION: Notice of meeting. 

SUMMARY: The Presidential Commission 

for the Study of Bioethical Issues will 

conduct its fifth meeting in May. At this 

meeting, the Commission will discuss 

the topic of Federal standards regarding 

human subjects protection in Federally 

funded scientific studies. 

DATES: The meeting will take place 

Wednesday, May 18, 2011, from 9 a.m. 

to approximately 4:45 p.m., and 

Thursday, May 19, 2011, from 9 a.m. to 

approximately 1:15 p.m. 

ADDRESSES: The Warwick New York 

Hotel, 65 West 54th Street, New York, 

NY 10019. Phone 212–247–2700. 

FOR FURTHER INFORMATION CONTACT: 

Hillary Wicai Viers, Communications 

Director, Presidential Commission for 

the Study of Bioethical Issues, 1425 

New York Avenue, NW., Suite C–100, 

Washington, DC 20005. Telephone: 

202–233–3963. E-mail: 

Hillary.Viers@bioethics.gov. Additional 

information may be obtained at http:// 

www.bioethics.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act 

of 1972, Public Law 92–463, 5 U.S.C. 

app. 2, notice is hereby given of the fifth 

meeting of the Presidential Commission 

for the Study of Bioethical Issues 

(PCSBI). The meeting will be held from 

9 a.m. to approximately 4:45 p.m. on 

Wednesday, May 18, 2011, and from 9 

a.m. to approximately 1:15 p.m. on 

Thursday, May 19, 2011, at the Warwick 

New York Hotel, New York, NY. The 

meeting will be open to the public with 

attendance limited to space available. 

The meeting will also be webcast at 

http://www.bioethics.gov. 

Under authority of Executive Order 

13521, dated November 24, 2009, the 

President established PCSBI to serve as 

a public forum and advise him on 

bioethical issues generated by novel and 

emerging research in biomedicine and 

related areas of science and technology. 

The Commission is charged to identify 

and promote policies and practices that 

assure ethically responsible conduct of 

scientific research, healthcare delivery, 

and technological innovation. In 

undertaking these duties, the 

Commission will examine specific 

bioethical, legal, and social issues 

related to potential scientific and 

technological advances; examine 

diverse perspectives and possibilities 

for useful international collaboration on 

these issues; and recommend legal, 

regulatory, or policy actions as 

appropriate. 

The main agenda item for this fifth 

meeting is to review Federal as well as 

transnational standards of human 

subjects protections in scientific studies 

supported by the Federal government as 

requested by President Obama on 

November 24, 2010. 

The draft meeting agenda and other 

information about PCSBI, including 

information about access to the webcast, 

will be available at http:// 

www.bioethics.gov. 

The Commission welcomes input 

from anyone wishing to provide public 

comment on any issue before it. There 

will be a public comment session in the 

afternoon on May 18, 2011. Individuals 

who would like to provide public 

comment at that time should notify 

Esther Yoo by telephone at 202–233– 

3960, or e-mail at 

Esther.Yoo@bioethics.gov before May 9, 

2011. To accommodate as many 

speakers as possible the time for each 

individual to speak may be limited. If 

the number of individuals wishing to 

speak is greater than can reasonably be 

accommodated during the scheduled 

meeting, the Commission may randomly 

select speakers from among those who 

register to speak. 

Anyone planning to attend the 

meeting who needs special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should also notify Esther Yoo (contact 

information above) in advance of the 

meeting. The Commission will make 

every effort to accommodate persons 

who need special assistance. 

Written comments will also be 

accepted and are especially welcome. 

Please address written comments by email to info@bioethics.gov, or by mail to 

the following address: Public 

Commentary, Presidential Commission 

for the Study of Bioethical Issues, 1425 

New York Ave., NW, Suite C–100, 

Washington, DC 20005. Comments will 

be publicly available, including any 

personally identifiable or confidential 

business information that they contain. 

Trade secrets should not be submitted. 

Dated: April 6, 2011. 

Valerie H. Bonham, 

Executive Director, Presidential Commission 

for the Study of Bioethical Issues. 

[FR Doc. 2011–9123 Filed 4–14–11; 8:45 am] 

BILLING CODE 4154–06–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10369] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: New collection; Title of 

Information Collection: Solicitation for 

Applications: Community-based Care 

Transitions Program; Use: The 

Community-based Care Transitions 

Program (CCTP) described in Section 

3026 of the Affordable Care Act will run 

for 5 years with a mandated start date 

of January 1, 2011. This program 

provides funding to community-based 

organizations in partnership with acute 

care hospitals for the provision of care 

transition services delivered to high risk 


srobinson on DSKHWCL6B1PROD with NOTICES